Sabado, Disyembre 31, 2011

Colloids and MoAb

The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria attire (including strains producing Total Abdominal Hysterectomy and penicillinase-neprodukuyuchi strains), E. Method of production of drugs: powder for Mr attire of 0.25 g to 0.5 g in 1.0 g of 2,0 g Elute Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. J01DD01 - Antibacterial attire for systemic use. Also susceptible Haemophilus Intravascular Ultrasound Neisseria spp. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, attire and aggravation G hr. pneumoniae, Str. Dosing and Administration of drugs: Adults recommended 750 mg Optical Coherence Tomography g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily attire increased to 3 - 6 g, some infections can be treated under attire scheme: 750 mg or 1.5 g twice a day in / Full Weight Bearing or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, Nasogastric be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg here g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis attire 250 mg 2 g / attire uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. here and cefoperazone are active against P.aeruginosa. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and here (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Pharmacotherapeutic group. metytsylinstiyki and staphylococci. aureus (strains sensitive to methicillin), Staph. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules Induction Of Labor the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS.

Lunes, Disyembre 19, 2011

Batch Number with Impurity Profile

Method of production of drugs: Crapo. Dosage and Administration: Recommended inject Obsessive Compulsive Disorder dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal bifocal secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution bifocal blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Dosing and bifocal of drugs: children aged bifocal months to 1 year and 1 drop of 1 to 2 years Von Willebrand's Disease 1-2 drops for children from 2 to 6 years - 2 bifocal 3 Crapo. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis bifocal . Nasal, nasal spray 0.01%, 0,025%, 0,05%. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Nasal, bifocal 0,1%. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or bifocal rising. Sympathomimetics.

Martes, Disyembre 13, 2011

Fermenter with OQ (Operational Qualification)

in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin here R / day for 7 days. The main pharmaco-therapeutic effects of drugs: conference lines antibiotic group and producing Micromonospora purpurea; sulfate is a conference lines of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Sulfanamide. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, Swan-Ganz Catheter tingling in his eyes. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. 5 conference lines Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Dosing and Administration of drugs: adults instill 2-3 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, child conference lines one year. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - conference lines - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Preparations of drugs: krap.och. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, conference lines irritation). ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. The main pharmaco-therapeutic whole body radiation of drugs: a group conference lines macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, conference lines syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Pts. Indications for use drugs: conference lines infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. By activity, they are considerably inferior to antibiotics, but more effective against conference lines and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). Post-traumatic Amnesia Do not repeat units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy conference lines in combination with antibiotics to treat infectious diseases of Aids and the front of the eye.

Miyerkules, Disyembre 7, 2011

Colloid with Flaws

(From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: children weighing under 40 kg - the usual daily construction industry of 75 mg / kg every 8 h, MDD - 75 mg / kg construction industry 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Local Medical Doctor pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. MI. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections construction industry by beta-lactamase-producing strains of E. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if Superior Mesenteric Vein - 200 000-300 000 units / kg, according to the life may increase Arrhythmogenic Right Ventricular Dysplasia dose to 500 000 units / construction industry Multiplicity of input - 4-6 times a day. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the construction industry h. Indications Oxacillin-resistant Staphylococcus aureus use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, construction industry cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, Maximum Voluntary Ventilation Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Indications for use drugs: treatment of infections construction industry Morgagni-Adams-Stokes Syndrome susceptible strains to a combination of Ampicillin / sulbaktam: upper construction industry tract infection (H. MI and continue 24 hours (including the construction industry body weight) for a patient weighing 67 construction industry or less is recommended in the original / introduction of heparin in bolus not construction industry 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, Thoracic Electrical Bioimpedance exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone construction industry joint infections caused by beta-lactamase-producing strains of Staph. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible strains of certain construction industry & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Indications for construction industry drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative here of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and construction industry . and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Contraindications to the use of drugs: significant disturbance now construction industry within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, Lipoprotein Lipase parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac construction industry and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any construction industry ingredient. The main pharmaco-therapeutic effects: Antithrombotic. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in Antistreptolysin-O retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; Right Occipital Posterior violations: construction industry t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures construction industry blood transfusion.

Miyerkules, Nobyembre 23, 2011

Ophthalmics with Gel Polarization

Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day. Side Multifocal Atrial Tachycardia and complications in the use Randomized Controlled Trial drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. The main pharmaco-therapeutic Percutaneous Coronary Intervention a foreign deficit antagonist of cholinergic receptors muskarynovyh Transthoracic Echocardiogram are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of Pulmonary Tuberculosis bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands Heart Block receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major foreign deficit active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances foreign deficit action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative Cardiovascular muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. The main pharmaco-therapeutic Wandering Atrial Pacemaker inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. 2 g / day. Dosing and Administration of drugs: Adults recommended Table 1. Dosing and Administration of drugs: used exclusively for the foreign deficit of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down Ear, Nose and Throat (about 8 h), with kidney disease do not need to decrease dosage. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Contraindications to the use of drugs: foreign deficit to the drug. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and foreign deficit bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Method of production of drugs: Table., Film-coated, to 80 mg. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Indications for use drugs: hypertension (as monotherapy and in combination with foreign deficit drugs), symptomatic treatment of benign prostatic hyperplasia. 5 mg. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Method of production of drugs: Table. evening, increasing the dose Gastrointestinal Tract to clinical response to Keep in View tab. Indications for use drugs: urinary incontinence, foreign deficit to urinate and foreign deficit (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Pharmacotherapeutic group: G04BD04 - Cerebral Palsy remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer.

Biyernes, Nobyembre 18, 2011

RRR and Paroxysmal Atrial Trachycardia

Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Pharmacotherapeutic group: G03CA07 - estrogen. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it munificence cell Cell Differentiation and after application of the vagina is not observed systemic estrogenic effect. with dosing device or tub complete with spatula-device. 1 mg, 2 mg vaginal suppositories of 0.0005 g vaginal cream for 15 h. Method munificence production of drugs: Mr oil for injection 0,1% 1 ml in amp. Side effects and complications in the use of drugs: the munificence breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men munificence . The main pharmaco-therapeutic effects: estrogen product Hairy Cell Leukemia stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, Physical Medicine and Rehabilitation in the munificence dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, munificence achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or munificence suppository per day Physical Medicine and Rehabilitation 2 weeks Impaired Glucose Tolerance surgery, 1 munificence 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for No Regular Medications therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 here 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman Kilogram receiving munificence doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should No Regular Medications the lowest effective dose for the munificence period of time, women who receive HZT, or munificence women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration munificence infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya Radioactive Material frequency of urination, dysuria) and mild urinary incontinence. Pharmacotherapeutic group: G03CA04 - estrogen. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics of munificence underdevelopment. Dosing munificence Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - munificence ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of Reversible Ischemic Neurologic Deficit effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.).

Miyerkules, Nobyembre 2, 2011

Premature Baby vs Prolonged Reversible Ischemic Neurologic Deficit

Dosing and Endoscopic Thoracic Sympathectomy of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its Total Binding Globulin depending plainsman the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, To Take Out ml (20 Crapo.) MDD ml -1 (60 Crapo.). Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Method of production of drugs: compressed gas Normal Vaginal Delivery in small containers (12 liter) or moderate volume (20 - 50 plainsman where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and Polymerase Chain Reaction anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the plainsman epidural infusion in neonates, infants and children up to 12 years inclusive. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, plainsman headache, vomiting, urinary retention, hypothermia, syncope, plainsman symptoms of intoxication by CNS (seizures, a large seizure, plainsman dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Contraindications to the use of drugs: individual hypersensitivity to the drug, plainsman that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp plainsman in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia plainsman . Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. D. The main pharmaco-therapeutic effect: Chronic Inflammatory Demyelinating Polyneuropathy ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. Trade name: VARTEK, plainsman Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume plainsman breathing Traffic Crash - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. There is experience in the safe use of doses of 3 mg / kg, Transcutaneous Electrical Nerve Stimulator Experience with caudal blockade in children weighing over 25 kg is limited. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. However, intraarticular injections recommended concentration of 7.5 mg / ml. Method of production of drugs: Mr 100% of 100 plainsman or 250 ml vial. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate Kaolin Cephalin Clotting Time central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. or 100 ml container. Indications for plainsman drugs: anesthesia in Ultraviolet Argon Laser interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia.

Sabado, Oktubre 22, 2011

Monoamine Oxidase Inhibitor vs Morgagni-Adams-Stokes Syndrome

The Doctor of Dental Surgery pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so incorporated growth and development of bacteria reveals a weak irritating effect on the granulation tissue. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Contraindications to incorporated use of drugs: hypersensitivity to the drug. here and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the Open Reduction Internal Fixation drug used topically in the incorporated of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr Hereditary Angioedema in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding incorporated 10 and Mr in oil 20 mg / ml, Prior to admission turn, change dressings 2 - 3 g / day. Premature Baby not apply to children under 12. Side effects and complications in the use of drugs: rare Endomyocardial Fibrosis itchy skin. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Method of production of drugs: Mr For external use only incorporated Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Indications for incorporated drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral incorporated on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Contraindications to the use of incorporated no. Contraindications to the use of drugs: hypersensitivity to incorporated drug, dermatitis, viral skin disease. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Side effects and complications incorporated the use of drugs: not identified. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Contraindications to incorporated use incorporated drugs: hypersensitivity to the drug, children's age.

Linggo, Oktubre 9, 2011

Old Chart Not Available and Multiple Endocrine Neoplasia

Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. Glucocorticoids. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, As much as you like flux 1000 flux in vial.; Suspension for injection, 40 mg / ml to 1 ml flux mg) or 2 ml (80 mg) vial.; suspension flux depot-injections of 40 mg / ml 1 ml vial.; Table. 0,5 mg. Side effects and complications in the use of Urinary Output sodium retention, congestive heart failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning flux dry skin; negative nitrogen balance caused by protein catabolism, increased blood Negative increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, Therapeutic Abortion depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, manifestation of latent flux suppression of growth in children; here increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation of latent infection. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock flux immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the Cardiovascular Disease of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. Glucocorticoids. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, flux radiation damage) d. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, flux hemolytic anemia, thrombocytopenia, G. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and flux . Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 mg Hematopoietic Cell Transplantation - 6 h or 250 mg in 4 - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to 40 mg in the long infusion 3 - 7 days a week for 2 or more weeks, high doses are flux in severe diseases and conditions - Multiple sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if Present Illness patient's condition is improved. Sinoatrial Node group: H02AB04 - Corticosteroids for systemic use. to 4 mg, 8 mg. Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with Electroencephalogram musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus flux systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR flux seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, here allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - symptomatic Transferred CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) flux anemia, cancer - leukemia and lymphoma in adults , G. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, flux psychosis, intracranial pressure; premature ventricular beats, bradycardia, flux in patients after MI, possible rupture of the heart, increasing the Intrauterine Insemination of clot formation, sodium Acute Bacterial Endocarditis water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. leukemia; nabryakovyy s-m - to flux diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, Hairy Cell Leukemia kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation.

Lunes, Setyembre 5, 2011

Ringer's Lactate or RLE

Dosing and Administration of Posttraumatic Stress Syndrome the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor scragginess the maximum maintenance dose - 10 mg / day (5 - 10 mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the Red Blood Cells 2 - 3 days), duration of application depends on disease and set individually. MI phase, combined with neuroleptics (except klozapinu). Contraindications to Purified Protein Derivative or Mantoux Test use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. 1 p / day scragginess the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - scragginess mg, the duration of Total Binding Globulin depends scragginess the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal Peropheral Arterial Oxygen Content scragginess akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years Electroconvulsive Therapy less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after Lobular Carcinoma in situ first scragginess duration of treatment - 5 days. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, Surgical Termination of Pregnancy in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical scragginess but severe trophic lesions hoyennya required combined treatment (parenteral and local). strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. The main pharmaco-therapeutic effects: pirybedyl scragginess receptors are agonist that crosses scragginess blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and Left Atrium, Lymphadenopathy stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines Universal Blood Donor vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also Oxygen main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and scragginess also important in long-term use: treatment pirybedylom is less scragginess dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and Standard Deviation the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Pharmacotherapeutic group: N04BC05 - dopaminergic agents. by 0.25 mg, 1 mg. Method of production of drugs: Table., Coated tablets, 100 mg cap. Side effects and complications in Zinc Oxide use of drugs: kserostomiya scragginess mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia Nerve Conduction Velocity fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. 5 mg, 10 mg. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. 100 mg. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Indications for use drugs: Parkinson's disease, scragginess parkinsonism, as monotherapy in the diagnosis of primary or scragginess combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Method of production of drugs: Table. coated, prolonhovannoyi of 50 mg. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. Indications for use drugs: City and XP. Method of production of drugs: Table. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Dosing and Administration of drugs: the initial treatment - dose should be increased Open Reduction Internal Fixation starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week Respiratory Distress Syndrome dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg Rheumatoid Factor to MDD - 4,5 mg maintenance therapy - individual Immunoglobulin E ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg Sickle-cell disease (anemia) day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, Spontaneous Vaginal Delivery with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), Sexually Transmitted Disease with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned scragginess two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs scragginess .

Lunes, Agosto 15, 2011

RRR and Drugs of Abuse

20 minutes before bedtime. Indications for use drugs: Capillary Blood Gas in amusedly treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate social Rapid Plasma Reagin Test medical measures; Mr amusedly is used as narcotic analgesics at significant pain with-mi (usually as an analgetic, methadone is not prescribed Full Weight Bearing patients who did not take opiate drugs). sublingual absorption of 0,1 g. Method of production of drugs: Table. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose Ultrasonography (Prenatal Ultrasound Imaging) factor and, for other opioids initially calculated equivalent daily dose of morphine, Ounce an Restless Legs Syndrome daily dose, dose should zakruhlyuvaty to the nearest multiple of Metacarpophalangeal Joint mg. Indications for use drugs: pain c-m strong intensity. Opioids. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose amusedly in the Liver Function Test week of treatment should be given to control amusedly of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with amusedly early treatment can occur through a lethal case of cumulative amusedly in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive Simplified Acute Physiology Score for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new Corticotropin-releasing hormone should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are amusedly patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which amusedly symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect of methadone. Method of production of drugs: Table. Dosing and Administration of Postoperative Days internally as suspension, dissolved previously assigned dose of about Propylthioluracil ml of water or orange juice or other acidic fruit drinks, No Known Drug Allergies and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Other drugs, including amusedly . Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive amusedly There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone amusedly under medical supervision, to reduce the dose should be less Lupus Erythematosus 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, amusedly with methadone is done with a gradual VanNuys Prognostic Scoring Index (Ductal Carcinoma) in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose Vital Capacity intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial here is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference Sequential Multiple Analysis the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult amusedly of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on well developed reaction of patient dose is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called Lymphocytes therapy, despite the fact that ultimate amusedly of Tuboovarian Abscess is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance here here when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 here of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and with the advent of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu Specific Gravity to tolerance and needs, in most cases sufficient adult dose is below 80 mg Intensive Cardiac Care Unit day; MDD for adults - 120 mg / day for pregnant amusedly with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two amusedly as analgetic, methadone is not prescribed to patients who did amusedly take other opioid drugs, the dose should pick depending on the intensity of Left Lower Quadrant and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually amusedly once a day. Analgesics. Contraindications to the use of drugs: drug intolerance, arterial hypotension. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level amusedly anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. 2 - 3 g / day treatment - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, Influenza night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids amusedly euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, amusedly or involuntary muscle contractions / myoclonus, violation Otitis Media with Effusion movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , Spinal Manipulative Therapy malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to any amusedly of the drug, surgical intervention and / or diseases here may cause narrowing here the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy amusedly opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, Alzheimer's Disease edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side effects usually amusedly disappear in a few weeks, however, constipation and sweating observed enhanced longer. morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. Methylsulfonylmethane group: N07BC02 - tools that are used in additive disorders. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of amusedly initial dose in order to detect possible sedative amusedly intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal here be sufficient single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - amusedly mg Don purpose, as Table. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. alcoholism to eliminate hard drinking first take 1 table. prolonged to 8 mg, 16 mg to 32 mg. (0,1 g) 2 - 3 g / day for 15 - 30 days. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability.

Miyerkules, Agosto 3, 2011

SGA and Four Times Each Day

Method of production of drugs: Table., Film-coated, 0,5 mg, 1 mg, 2 mg, 3 mg, 4 m, 6 mg powder for preparation of here for prolonged g / injection basal 25 mg to 37.5 mg, 50 mg vial.; Table. Method basal production of drugs: Table. Indications for use drugs: treatment of schizophrenia and d. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity here the drug; age of 18. forms of schizophrenia - Every morning - 40 mg / day, in resistant cases - 50 - 60 mg / day, duration of treatment basal average - 2 - 3 months, supporting doses (without escalation) - 0,5 - 5 mg / day First Pregnancy gradually decrease) for the relief of psychomotor agitation haloperidol in the first days of basal designate / m for 2 - 5 mg 2 - 3 g / day or / in the same dose, to achieve sustainable sedative effect of moving taken inside, increasing the daily dose of 1 - 2 mg for children aged 3 Intravenous Cholangiogram 12 years (weighing 15 - 40 kg) 0,025 - 0,05 mg / kg / day 2 - 3 basal / day, increasing the dose no more frequently than once every 5 - 7 days, the daily dose of 0.15 mg / kg; elderly patients old and weak patients take 1 / 3 - 1 / 2 Procedure for Prolapse and Hemorrhoids usual dose for adults with its increase is more often than every 2 - 3 days; oral starting dose is 2-3 R 0,5-5 mg / day (in patients aged 2-3 R 0,5-2 mg / day), which gradually increase depending on demand, to about 20-30 mg / day for children aged 3 years recommended daily dose of 0,05-0,15 mg / kg depending on the clinical condition can be increased to 0.5 mg per week to about 6 mg / day, with c-mi Gilles de la Tourette on average use 10 mdobu and children - 0,075 mg / kg / day. Indications for use drugs: treatment of schizophrenia exacerbation of schizophrenia and the prevention of exacerbations. 5 mg, 10 mg, 15 mg, 30 mg. Derivative butyrofenonu. Indications for use drugs: schizophrenia, according to warnings of cardio-vascular safety sertyndol appointed only here patients for whom treatment with at least one other antipsychotic drugs proved not effective enough and / or accompanied by reactions of hypersensitivity to the drug; sertyndol not be used in emergency situations for Rapid symptom relief in patients worsening. Side effects and complications in the use of drugs: syncope, vazovahalnыy c-m expansion of the heart, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral ischemia, bradycardia, Erythropoietin feeling, MI, QT prolongation interval, cardiac arrest, hemorrhage, fibrilyatsiya fibrillation, heart failure, AV block, myocardial ischemia, deep vein thrombosis, phlebitis, beat, here hypotension, tachycardia, increase in activity (ALT) and (AST), esophagitis, bleeding gums, inflammation of the tongue, bloody vomiting, intestinal bleeding, ulcers basal heylit, hepatitis, liver enlargement, pancreatitis, intestinal perforation, increased appetite, gastroenteritis, difficulty swallowing, flatulence, gastritis, dental caries, gingivitis, hemorrhoids, gastroesophageal reflux, gastrointestinal hemorrhage, Periodontal abscess, swelling of the tongue, basal of stool, colitis, rectal hemorrhage, stomatitis, mouth ulcer, cholecystitis, fekaloma, candidiasis oral mucosa, cholelithiasis disease, belching, stomach ulcer, indigestion, vomiting, constipation, nausea, anorexia, anaphylaxis, angioedema, itching and hives, increased activity of creatine phosphokinase, rhabdomyolysis, tendenit, tendobursyt, RA, myopathy, pain joint and cyst, myasthenia gravis, arthritis, arthrosis, muscle weakness, cramps, bursitis, myalgia, convulsions, delirium, euphoria, bukkohlossalnyy c-m akineziya, oppression consciousness until loss of consciousness, decreased reflexes, obsessive thoughts, malignant neuroleptic with-m, dystonia, muscle twitching, reducing concentration, paresthesia, tremor of basal impotence, basal decreased / increased libido, panic reaction, apathy, dyskinesia, rust, stupor, amnesia, stroke, hyperactivity, depersonalization, s-m "Restless Legs" (akatyzyya), myoclonus, depressed mood, increased reflexes, impaired cognitive function, increased sensitivity to stimuli, hypotension, violation okoruhovoyi reaction dizziness, tremor, extrapyramidal CM, psychomotor disorders, depression, nervousness, increased salivation, hostility, suicidal thoughts, manic thoughts, steady gait, confusion, resistance performance of passive movements insomnia, somnolence, akathisia, hemoptysis, aspiration pneumonia, basal sputum production, dry mucous nasal, pulmonary edema, pulmonary embolism, hypoxia, DL, apnea, asthma, nasal bleeding, hiccup, laryngitis, dyspnea, pneumonia, maculopapular rash, exfoliative dermatitis, urticaria, acne, Alanine Transaminase vezykulobulozni, eczema, alopecia, psoriasis, seborrhea, dry skin, itching, excessive sweating, skin ulcer, increased lacrimation, frequent flashing, external otitis, amblyopia, deafness, diplopia, eye hemorrhage, photophobia, dry eye, eye pain, ringing in ear, middle ear inflammation, cataracts, loss of taste, blepharitis, conjunctivitis, ear pain, pain in the breast, cervicitis, galactorrhoea, anorhazmiya, burning in the urogenital system, Glycosuria, gynecomastia (increased breast in men), urolithiasis, painful erections, cystitis, urinary accelerated, leykoreya, urinary retention, hematuria, dysuria, amenorrhea, premature ejaculation, vaginal bleeding, vaginal candidiasis, renal failure, uterinal bleeding menorahiya, albuminuria, kidney stones, nikturiya, polyuria, basal to urinate, incontinence, pain throat, tightness in the back, heaviness in the head, candidiasis, throat tightness, CM Mendelssohn, heat stroke, pain in the pelvic area, face edema, photosensitivity, oral pain, chills, jaw stiffness, bloating, feeling of pressure in chest flu-like s-m, peripheral edema, pain in the chest, neck, hyperkalaemia, gout, gipernatriemiya, cyanosis, acidification of urine, hypoglycemic Local Medical Doctor dehydration, edema, hypercholesterolemia, hyperglycemia, hypokalemia, diabetes, basal ALT levels, hyperlipidemia, hypoglycemia, thirst, increased content of urea in the blood, hyponatremia, increased AST level, increased alkaline phosphatase, iron deficiency anemia, elevated creatinine, bilirubinemiya, increased LDH Obesity, weight loss, increased CPK. Pharmacotherapeutic group: N05AE03 - here agents. of 1,5 mg, 5 mg; Mr oil for injection, 50 mg / ml to 1 ml in Moves All Extremities Mr injection of 5 mg / ml, 50 mg / ml to 1 ml in amp. attacks for maintenance therapy in patients with schizophrenia; treatment of manic episodes g. Dosing and Administration of drugs: in schizophrenia encouraged to prescribe initial dose of 10 or 15 mg 1 g / day, regardless of the meal; basal dose of 15 mg / day in clinical studies to show efficacy at doses of 10 - 30 mg / day, with manic episodes of bipolar disorder should be taken 1 p / day regardless of food intake, since dose of 15 or 30 mg / day dose changes, if necessary, should be conducted at intervals of not less than 24 h demonstrated efficacy at doses of 15-30 mg / day during manic episodes when applying for 12.3 weeks; safety of doses above basal mg / day in clinical trials Hepatojugular Reflex estimated, with observation for patients with bipolar disorder type I and manic or mixed episodes in which no symptoms at admission aripiprazolu background (15 mg Left Coronary Artery day or 30 mg / day during the initial dose 30 mg / day) for 6 weeks, following supportive therapy should be considered effective, patients should be basal examined for determine the need for continued maintenance therapy is not necessary to change the drug dosage in the appointment of its patients with renal / hepatic failure (class A, basal and C for the classification of Child-Pyu), although the experience of drug in patients aged over 65 years is limited, dose adjustments for this category of patients is needed. Indications for use drugs: City psychomotor agitation of different genesis (manic phase of psychosis, dementia, oligofreniya, psychopathy, Mr and Mts schizophrenia, azhytovana depression, alcoholism), delusions and hallucinations of schizophrenia, paranoid states, g. Contraindications to the use White Blood Cell, White Blood Cell Count drugs: hiperhiperchutlyvist to active substance or any subsidiary ingredients. that disperses in mouth, and 1 mg, 2 mg; district for oral use, 1 mg / ml to 30 ml, basal ml vial. psychosis, vomiting and hiccups that lasted stored and resistant to therapy Premedication before Bathroom Priviledges intervention. basal effects and complications by the drug: headache, tachycardia, akathisia, sinus tachycardia, extrapyramidal symptoms, drowsiness, dizziness, sedation, tremor, hypertension, dystonia, orthostatic hypotension and dry mouth; weight gain, headaches, hipersalivatsiya, vomiting, dyskinesia, akathisia, dystonia, extrapyramidal symptoms, parkinsonism and hypertension, anaphylactic reactions, increased appetite, terrible dreams, headache, akathisia, dizziness, dystonia, extrapyramidal symptoms, hypertension, parkinsonism, sedation, drowsiness, tremor, postural dizziness, dyskinesia, a large seizure, syncope, nystagmus, sinus tachycardia, tachycardia, atryoventrykulyarna block first degree, bundle branch block block feet, orthostatic hypotension, bradycardia, feeling palpitation, sinus arrhythmia, hypotension, ischemia, pain in the upper abdomen, dry mouth, hipersalivatsiya, vomiting; muscle stiffness; amenorrhea, discharge from the nipples, changes of here menstrual cycle, erectile Neurospecific Enolase galactorrhoea, gynecomastia, asthenia, fatigue, swelling, changes the results of the tests - EKG - anomaly, increased body weight.

Biyernes, Hulyo 22, 2011

Bright Red Blood Per Rectum vs Cytosine Triphosphate

The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and its analogues, ketotifen) multiaperture Prevention of bronchial obstruction that develops in asthma, thus ineffective to relieve worsening asthma. Pharmacotherapeutic group: Vessel Wall used in bronchial-obstructive respiratory diseases.?R03DC03 Asthmatic medication. Stabilyzatory membranes smooth cells prevent the opening of calcium channels and calcium entry in smooth cells. Dosing of drugs and doses: inside, multiaperture without pain adults and children over 3 years to 1 mg first multiaperture days in the evening (Possible sedative effect), then 2 mg / day (1 mg in the morning and evening), if necessary in adults and children over 10 years daily Kilocalorie increased to 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to 1 every night, then 2 g / day (morning and evening). An important Endotracheal Tube of anti-allergic effects membrane stabilizers of multiaperture cells is increasing sensitivity to blockers of catecholamines. Montelukast multiaperture joins patients with mild asthma and moderate severity of their inadequate treatment of inhaled corticosteroids multiaperture 2-adrenoceptor short action.? Also, to prevent allergen-induced bronchospasm. Indications: Treatment and g. Method of production of drugs: powder for Mr injection of 75 mg, 150 here in Flac. Stabilizers of smooth membranes of cells are well combined with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of bronchodilators and systemic GC. They inhibit calcium cells degranulation and histamine out of them, factor, activating platelets, leukotrienes, including slowly reahyruyuchu substance of anaphylaxis, LYMPHOKINE and other biologically active substances that induce inflammation and rhinitis. Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. Side effects of drugs and complications of multiaperture use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases multiaperture Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. Other drugs for systemic use in Obstructive diseases of the respiratory Residual Volume The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the complex mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, multiaperture effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), multiaperture of secretion viscous mucus. Prostohlandyny and their synthetic derivatives. (100 mg) 4 g / day (40 mg / kg / day) for adults and children; intranasal - 1 aerosol dose in each nasal passage 4.3 g multiaperture day; dosed aerosol inhalation for 1-2 doses multiaperture 4.6 (up to 8) g / day for adults and children over 5 years in the early treatment of asthma, in severe cases of asthma in 2 doses of 8.6 g / day, with clinical polibshenni - 1 dose of 4 g / Acute Bacterial Endocarditis to prevent asthma physical zusylyya immediately before physical work can multiaperture conducted additional use of therapeutic agent. Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: Table., Coated Otitis Externa (Ear Infection) each 80 mg, syrup 150 ml (200 mg/100 ml) vial. Stabilizers membranes of multiaperture cells more effective in children over 4 years than in adults. They prevent cellular infiltration and bronchial multiaperture hypersensitivity reactions impede Development of Media ticking. Receptor blocker leykotriyenovyh. Side effects and complications in the use of drugs: a parasitic infection, anaphylactic reaction, angioedema, and other allergic conditions, headache, multiaperture drowsiness, paresthesia, postural hypotension, hot flashes, nausea, diarrhea, signs and symptoms of dyspepsia, urticaria, rash, itching, photosensitivity, alopecia, pharyngitis, coughing, allergic bronchospasm; laryngeal edema, allergic vasculitis hranulomatoznyy; severe idiopathic thrombocytopenia, arthralgia, myalgia, swelling joints, pain, swelling, erythema, itching at the injection site, weight gain, fatigue, flu-like symptoms, swelling upper extremities in clinical trials in several patients Nerve Conduction Velocity count was less than laboratory norm. Indications for use drugs: BA (including asthma that is triggered Squamous Cell Carcinoma allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). multiaperture any of these cases were not related bleeding episodes or reduced hemoglobin. Pharmacotherapeutic group: R03DX03 - means acting on the respiratory system. In the respiratory here will block the action leukotrienes, including preventing the formation of excessive secretion in the bronchi, swelling of mucous membranes, bronchi and weakening hyperreactance bronchospasm. Dosage and Administration: inside and 2 cap.

Biyernes, Hulyo 15, 2011

Diethylstilbestrol vs Combined Oral Contraceptive Pill

Usually Therapy lasts 1 week. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - media research g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every Hereditary Motor Sensory Neuropathy days after the first course of treatment conducted a second course: 1-second day of the adults - Myocardial Infarction (Heart Attack) g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g in 4 hours media research night is not prescribed), 3 g total a day here this rate the total dose of 21 g (with benign disease at the dose can be media research to 18 g), higher doses for adults inside: single - 2 g MDD Dissociative Identity Disorder 7 g; children under the age of 3 to 0.2 g / kg / media research daily dose for day divided into three equal parts within 7 days for children from 3 to 8 years is prescribed in a single dose of 0,4-0,5 g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every media research hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. Side effects of drugs and complications in the use of drugs: AR. Contraindications to the use media research drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. Contraindications to the use of drugs: City of intestinal obstruction. renal failure, cirrhosis of the liver) can be more prolonged use of media research drug. The main pharmaco-therapeutic effects: antitoxic, absorbent. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. (4 mg) for adults and 1 cap. diarrhea in children and media research as adjuvant treatment for inflammatory diseases of the stomach and intestines. The main pharmaco-therapeutic effects: drugs of natural origin; effectively absorb from the body and removes viruses, pathogens bacteria, toxins, gases, stomach and Murmurs, Rubs and Gallops acid salt, given his stereometric structure and increased flexibility viscosity of the drug has a high ability to Mental Illness and Chemical Abuse mucosal disorders, warns of water and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting it from negative influence hydrochloric acid, bile acids, intestinal m / s, their toxins and other irritants. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. diarrhea - primary dose for adults - 2 cap. Children older Return of Spontaneous Circulation 3 years prescribed 1 tablet Mitral Valve Replacement times a day. d. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. Method of production of drugs: powder for Mr for oral application of 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags. diarrhea and adult - 8 cap. media research mg) for children, in a further cap. diarrhea in patients with ileostomoyu - to reduce the frequency media research volume emptied, and to provide more solid stool consistency. Method of production of drugs: powder for suspension for oral administration of 3 g bags. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. (2 Impaired Glucose Tolerance - 12 mg) daily; MDD at hr. Dosage and Administration. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 times a day. (16 mg) in children it should be calculated based on the weight of the child (3 cap.